https://www.youtube.com/watch?v=4BfKFCOCJe8
Structured Modernization for Regulated Biometrics Environments

Biometrics Acceleration Sprint™

Learn More
Biometrics-Sprint-Image-1
Why This Sprint?

Most biometrics teams

do not require additional staff.

They require fewer bottlenecks, stronger traceability, and greater automation maturity.

The Sprint delivers structured, documented improvement within your existing architecture, aligned to your SOPs, your governance framework, and your regulatory obligations.

Schedule a Biometrics Acceleration Consultation →

Designed For

  • Small and mid-sized pharma sponsors managing biometrics in-house or through lean CRO models
  • Emerging biotech organizations approaching submission milestones with constrained programming bandwidth
  • CRO biometrics teams experiencing workflow friction across SDTM, ADaM, or TLF production
  • SAS programming groups under submission pressure seeking cycle time reduction
  • Sponsors seeking measurable, auditable improvement ahead of regulatory interactions
Pharms-Team-Biometrics
From Discovery to Measurable Impact

Program Framework.

1

Alignment and Scope Definition Phase

  • Stakeholder coordination and executive alignment
  • Defined modernization objectives with success criteria
  • Architecture access planning and security protocol coordination
  • Internal SME designation and communication cadence

Deliverable: Sprint Charter with defined scope, timeline, and governance alignment

2

Architecture and Workflow Discovery Phase

  • Infrastructure mapping across SAS, data management, and reporting environments
  • Programming pipeline review covering SDTM, ADaM, and TLF production workflows
  • QC loop analysis with cycle time baselining
  • Standards and metadata evaluation against current CDISC governance
  • Bottleneck risk assessment with prioritization scoring

Deliverables:

  • Architecture Blueprint
  • Acceleration Opportunity Matrix with prioritized recommendations
  • Risk Mapping Summary with regulatory impact assessment
3

Controlled Design Phase

  • Enhancement module specification with defined acceptance criteria
  • SOP alignment confirmation and change control planning
  • Validation structure definition aligned to GAMP 5 principles
  • 21 CFR Part 11 compliance review for any automated components

Deliverables:

  • Acceleration Design Specification
  • Validation Plan with traceability matrix
4

Implementation Phase

Enhancement modules are selected based on discovery findings and may include:

  • Code refactoring of high-friction derivation logic across SDTM and ADaM programs
  • Automation scripting for repetitive derivations, merges, and standardization tasks
  • RBQM Enhancements / Implementation
  • DM Issue Management Systems (Automated)
  • QC anomaly detection tools to reduce manual review burden
  • Traceability reinforcement frameworks linking specifications through final outputs
  • TLF template engineering for reproducible, audit-ready reporting pipelines
  • Pinnacle 21 integration optimization for continuous compliance monitoring
  • Dataset-JSON readiness preparation for modernization alignment

Modernization Pathway Assessments:

  • SAS Viya migration readiness evaluation and pipeline transition planning
  • R and Python adoption pathway assessment for SDTM/ADaM derivation modernization
  • Spotfire integration opportunity mapping for clinical data visualization
  • Global programming library optimization strategy with modular architecture recommendations

Deliverable: All changes are documented, reviewable, and designed for regulatory defensibility. No implementation occurs without change control approval.

5

Measurement and Transition Phase

Measured against baseline performance metrics established in Phase 2:

  • Programming cycle time reduction (SDTM, ADaM, and TLF production)
  • Manual step reduction with automation coverage quantification
  • QC defect frequency and rework cycle improvement
  • Programming efficiency gains with throughput comparison
  • Traceability completeness improvement

Deliverable: Biometrics Acceleration Impact Report with quantified results, methodology documentation, and prioritized next-phase recommendations

Exclusions

Typical program duration ranges between 12 and 24 weeks (on average) depending on environment complexity, stakeholder availability, and validation cycle requirements.

Expected Outcomes

  • Quantified performance improvement with documented baseline-to-result metrics
  • Strengthened operational control with reduced manual dependencies
  • Clear modernization roadmap with defined next-phase optimization pathway
  • Audit-ready documentation of all implemented enhancements
  • Internal capability uplift through knowledge transfer and documentation
Part of the INNOVIZZ Clinical Biometrics Practice
The Biometrics Acceleration Sprint™ is the primary structured engagement within the INNOVIZZ Clinical Biometrics Modernization practice, our dedicated capability for sponsors who require enterprise-grade biometrics optimization without enterprise overhead.
Let's Make It Happen

Begin Structured Acceleration

Schedule a Biometrics Acceleration Consultation to discuss your environment, your timeline constraints, and where structured modernization can deliver the most measurable impact.

Schedule a Biometrics Acceleration Consultation